Search research articles
Contact Us
Filters
Showing results (21-30 of 227) with videos related to
Page
of 23
Sort By:
Clinical Immunology and Immunopathology
|
October 1, 1995
Interleukin 6 during active visceral leishmaniasis and after treatment
T van der Poll, E E Zijlstra, M Mevissen
The Journal of Antimicrobial Chemotherapy
|
August 2, 2001
Erythromycin inhibits Pseudomonas aeruginosa-induced tumour necrosis factor-alpha production in human whole blood
M J Schultz, P Speelman, T van der Poll
Progress in Clinical and Biological Research
|
January 1, 1994
Endotoxin and the release of tumor necrosis factor receptors
J Jansen, T van der Poll, S J van Deventer
Nederlands Tijdschrift Voor Geneeskunde
|
April 29, 1998
[Immunology in clinical practice. VIII. Role of cytokines in the pathogenesis of bacterial infections]
T van der Poll, P Speelman, S J van Deventer
Seminars in Thrombosis and Hemostasis
|
December 12, 2001
Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience
E de Jonge, T van der Poll, J Kesecioglu, et al.
The Netherlands Journal of Medicine
|
March 30, 2011
Tired of Lyme borreliosis. Lyme borreliosis in the Netherlands
J Coumou, T van der Poll, P Speelman, et al.
The European Respiratory Journal
|
October 3, 2008
Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia
I A J Giebelen, M Leendertse, S Florquin, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Interferon-gamma protects against biomaterial-associated Staphylococcus epidermidis infection in mice
J J Boelens, T van der Poll, J Dankert, et al.
Critical Care Medicine
|
September 28, 2000
Novel approaches to the management of disseminated intravascular coagulation
M Levi, E de Jonge, T van der Poll, et al.
The Netherlands Journal of Medicine
|
September 11, 2012
Effect of the factor V Leiden mutation on the incidence and outcome of severe infection and sepsis
M Schouten, C van 't Veer, T van der Poll, et al.
Page
of 23
Search research articles
Search
Showing results (21-30 of 227) with videos related to
Sort By:
Page
of 23
Clinical Immunology and Immunopathology
|
October 1, 1995
Interleukin 6 during active visceral leishmaniasis and after treatment
T van der Poll, E E Zijlstra, M Mevissen
The Journal of Antimicrobial Chemotherapy
|
August 2, 2001
Erythromycin inhibits Pseudomonas aeruginosa-induced tumour necrosis factor-alpha production in human whole blood
M J Schultz, P Speelman, T van der Poll
Progress in Clinical and Biological Research
|
January 1, 1994
Endotoxin and the release of tumor necrosis factor receptors
J Jansen, T van der Poll, S J van Deventer
Nederlands Tijdschrift Voor Geneeskunde
|
April 29, 1998
[Immunology in clinical practice. VIII. Role of cytokines in the pathogenesis of bacterial infections]
T van der Poll, P Speelman, S J van Deventer
Seminars in Thrombosis and Hemostasis
|
December 12, 2001
Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience
E de Jonge, T van der Poll, J Kesecioglu, et al.
The Netherlands Journal of Medicine
|
March 30, 2011
Tired of Lyme borreliosis. Lyme borreliosis in the Netherlands
J Coumou, T van der Poll, P Speelman, et al.
The European Respiratory Journal
|
October 3, 2008
Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia
I A J Giebelen, M Leendertse, S Florquin, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Interferon-gamma protects against biomaterial-associated Staphylococcus epidermidis infection in mice
J J Boelens, T van der Poll, J Dankert, et al.
Critical Care Medicine
|
September 28, 2000
Novel approaches to the management of disseminated intravascular coagulation
M Levi, E de Jonge, T van der Poll, et al.
The Netherlands Journal of Medicine
|
September 11, 2012
Effect of the factor V Leiden mutation on the incidence and outcome of severe infection and sepsis
M Schouten, C van 't Veer, T van der Poll, et al.
Page
of 23